Results 21 to 30 of about 41,559 (216)
Mumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012
Western Pacific Surveillance and Response, 2012 Introduction: Mumps-containing vaccine was licensed in the 1990s in China with a single dose administered routinely to children aged 18–24 months since 2008.
Su Qi-ru +6 more
doaj +1 more source
Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China
Human Vaccines & Immunotherapeutics, 2022 Mumps cases were reported frequently when a routine dose measles–mumps–rubella(MMR) achieved high coverage in Quzhou. The supplementary immunization activities (SIA) using measles mumps (MM) was conducted to control mumps outbreaks.
Zhiying Yin +7 more
doaj +1 more source
Epidemics, 2022 Recent mumps outbreaks among highly vaccinated populations, including college students, have called into question the vaccine effectiveness (VE) of routine two-dose measles, mumps, and rubella (MMR2) immunization. We aimed to estimate the VE required for
Michael Melgar +2 more
doaj +1 more source
Post vaccinal temporary sensorineural hearing loss [PDF]
, 2018 In our systematic research we identified four studies concerning the onset of neurological adverse events following vaccination and two excluding this association.
De Cesare, Donato Pompeo +8 more
core +1 more source
The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya [PDF]
, 2009 Background Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infection in infants. The rate of decay of RSV-specific maternal antibodies (RSV-matAb), the factors affecting cord blood levels, and the relationship between ...
Charles Sande +7 more
core +9 more sources
Characteristics of 5-year-olds who catch-up with MMR: findings from the UK Millennium Cohort Study [PDF]
, 2013 Objectives To examine predictors of partial and full measles, mumps and rubella (MMR) vaccination catch-up between 3 and 5 years. Design Secondary data analysis of the nationally representative Millennium Cohort Study (MCS).
Bedford, Helen +3 more
core +2 more sources
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
mBio, 2020 The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients ...
Jeffrey E. Gold +9 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Between 18 Dec 2017 and 27 June 2018, a mumps outbreak occurred in two Canadian Indigenous communities. An outbreak dose of mumps-containing vaccine was offered as part of control measures.
Wallis Rudnick +6 more
doaj +1 more source
Эпидемиология и вакцинопрофилактика, 2021 Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles,
I. V. Feldblium +9 more
doaj +1 more source
A mumps model with seasonality in China
Infectious Disease Modelling, 2017 Background: Mumps, an infectious viral disease, classically manifested by inflammation of salivary glands and is best known as a common childhood viral disease with no specific treatment.
Qianqian Qu +5 more
doaj +1 more source